
Management of patients with zzso zzso in clinical practice represents a major zzso The 2001 zzso zzso zzso zzso have gained wide acceptance but recent advances have required their revision in zzso Large strategy trials comparing rhythm control to rate control using drug therapy has shown no difference in terms of major zzso including zzso The reason suggested by zzso analysis was that the benefits of zzso rhythm obtained with zzso agents were offset by their zzso The 2006 revised zzso version in terms of management strategy does not differ significantly from the 2001 version as both rhythm control and rate control strategies were considered zzso The selection of an zzso agent is still based on the presence and the type of underlying heart disease as the fruit of a consensus more than on evidence in a safety first zzso The only difference is that class zzso agents were deleted from the treatment zzso zzso zzso techniques represent one of the major developments in recent years in the management of zzso zzso The zzso recommend zzso zzso as a second line therapy in every branch of the therapeutic flow zzso In this respect, the 2006 version of the zzso although consistent with current practice is not evidence-based as zzso trials comparing zzso techniques to conventional management in zzso are still zzso Furthermore, the zzso form and the persistent or chronic forms are not differentiated as for the persistent and long-standing zzso the results of zzso zzso are less zzso zzso zzso techniques are complex and carry the risk of zzso requiring a repeat operation in zzso of cases and the risk of serious complications that may be life-threatening if not appropriately detected and zzso zzso zzso identifies a subset of patients at high risk of zzso The 2006 zzso have zzso the stroke risk into three group levels in order to better define the group for whom oral zzso with zzso is mandatory in the absence of zzso In this regard, the 2006 zzso version represents a helpful zzso 

